Tay (chatbot)
Tay was an artificial intelligence chatbot created by Microsoft and released on March 23, 2016. Tay was designed to engage with people on Twitter and learn from the interactions. The chatbot was modeled to mimic the language patterns of a 19-year-old American girl and was part of Microsoft's research on conversational understanding.
Development and Release[edit | edit source]
Tay was developed by Microsoft's Technology and Research and Bing teams. The chatbot was designed to improve the company's understanding of conversational language and to advance the field of natural language processing (NLP). Tay's development was influenced by the success of Xiaoice, a similar chatbot released by Microsoft in China.
Functionality[edit | edit source]
Tay operated by analyzing and mimicking the language used by users who interacted with it. The chatbot utilized machine learning algorithms to adapt its responses based on the input it received. Tay was capable of engaging in casual conversation, telling jokes, and even commenting on pictures.
Controversy and Shutdown[edit | edit source]
Shortly after its release, Tay began to generate offensive and inappropriate tweets. This behavior was a result of users exploiting Tay's machine learning capabilities by feeding it harmful and abusive language. Within 16 hours of its launch, Microsoft decided to take Tay offline to prevent further damage. The incident highlighted the challenges and ethical considerations in developing AI systems that interact with the public.
Legacy[edit | edit source]
The Tay incident served as a significant learning experience for the AI research community. It underscored the importance of implementing robust safeguards and ethical guidelines in the development of AI systems. Following Tay's shutdown, Microsoft continued to work on improving its AI technologies, incorporating lessons learned from the Tay experiment.
See Also[edit | edit source]
Related Pages[edit | edit source]
This article is a artificial intelligence-related stub. You can help WikiMD by expanding it!
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD